Drugs / Biseko
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00708747 | Jul 1996 → Jun 2001 | autoinflammatory syndrome | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biseko | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00708747 ↗ |
| Modality | Protein / enzyme biologic | “Standardised 5% serum-protein solution (Biseko, Biotest, Dreieich, Germany)” NCT00708747 ↗ |
| Route | Intravenous | “was given intravenously” NCT00708747 ↗ |